The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
Open accessAbstract
Transgenic mice carrying disease-linked forms of genes associated with Alzheimer disease often demonstrate deposition of the beta-amyloid as senile plaques and cerebral amyloid angiopathy. We have characterized the natural history of beta-amyloid deposition in APPswe/PS1dE9 mice, a particularly aggressive transgenic mouse model generated with mutant transgenes for APP (APPswe: KM594/5NL) and PS1 (dE9: deletion of exon 9). Ex vivo histochemistry showed Abeta deposition by 4 months with a progressive increase in plaque number up to 12 months and a similar increase of Abeta levels. In vivo multiphoton microscopy at weekly intervals showed increasing beta-amyloid deposition as CAA and plaques. Although first appearing at an early age, CAA progressed at a significantly slower rate than in the Tg2576 mice. The consistent and early onset of beta-amyloid accumulation in the APPswe/PS1dE9 model confirms its utility for studies of biochemical and pathological mechanisms underlying beta-amyloid deposition, as well as exploring new therapeutic treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As previously shown, human APOE alleles targeted to APPSW/PS1dE9 mice reproduce their differential effect on the magnitude of Aβ plaque load [13] but do not delay onset of Aβ deposition compared to APPSW/PS1dE9 mice expressing native murine apoE [14].”
From Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice (2014) · cites this paper as [14]
In the citing paper
“The APP SW /PS1 dE9 line represents a Tg model with enhanced disease phenotype, whereby the first plaques are detected by thioflavin-S at the age of 4 months.54”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [54]
Citations
Cites
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.262.18.2551 · Cited by 1,627
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,486
Self-citationHolcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Self-citationO'Brien, J. T., Erkinjuntti, T., Reisberg, ., Román, G. C., Pantoni, L., Bowler, J., Ballard, C., DeCarli, C., Gorelick, P., Rockwood, K., et al. (2014) · International Journal of Stroke · doi:10.1111/ijs.12374_18 · Cited by 1,165
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–748 of 748
Calvo-Rodríguez, M., Kharitonova, E. K., Snyder, A. C., Hou, S. S., Sanchez-Mico, M. V., Das, S., Fan, Z., Shirani, H., Nilsson, K. P. R., Serrano‐Pozo, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25026030
Self-citationCalvo-Rodríguez, M., Kharitonova, E. K., Snyder, A. C., Hou, S. S., Sanchez-Mico, M. V., Das, S., Fan, Z., Shirani, H., Nilsson, K. P. R., Serrano‐Pozo, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25025954
Self-citationLi, Q., Peng, J., Luo, Y., Zhou, J., Li, T., Cao, L., Peng, S., Zuo, Z., & Wang, Z. (2022) · Figshare · doi:10.6084/m9.figshare.20070793
Wang, S.-S., Liu, Z.-K., Liu, J.-J., Cheng, Q., Wang, Y.-X., Liu, Y., Ni, W.-W., Hongzhuan, C. H. E. N., & Song, M. (2021) · Figshare · doi:10.6084/m9.figshare.15569164
Mouse models of Alzheimer’s disease pathology
Kim, S., & Gray, N. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29090-9.00004-0
Kushwaha, S., & Karunakaran, S. (2026) · Research Square · doi:10.21203/rs.3.rs-7591768/v2
The Proteome of Human Amyloid Beta Oligomers
Kass, B., Poschmann, G., Demir, F., Huesgen, P. F., Stühler, K., Kutzsche, J., & Willbold, D. (2026) · Biochemistry · doi:10.1021/acs.biochem.5c00597 · Cited by 1
Amyloid-β and tau pathology induce a reduction of the G-protein Gαo subunit in the mouse hippocampus
Aguado, C., Martínez-Poyato, M. L., Martín‐Belmonte, A., Alfaro‐Ruiz, R., Moreno‐Martínez, A. E., & Luján, R. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103436
Optimal HAEE synthetic peptide therapeutic dose with repeated administration to APP/PS1 mice
Козин, С. А., Лысикова, Е. А., Yakovlev, R., Mukhina, K. A., Soloveva, A. M., Shmigol, T. A., Makarov, A. А., & Mitkevich, V. A. (2026) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2026.006
Garland, I. J. Z., Engel, S., Scalf, M., Payne, N. R., Lee, A. M., & Graves, S. M. (2026) · Neurotoxicity Research · doi:10.1007/s12640-026-00794-2
Impact de l’infection à Helicobacter pylori sur la maladie d’Alzheimer
Baudron, C. R. (2014) · theses.fr (ABES) · doi:10.70675/201f68e4z646cz4e66z80e2zd8a4b726fbe7
IVIM : modélisation, validation expérimentale et application à des modèles animaux
Fournet, G. (2016) · theses.fr (ABES) · doi:10.70675/9684556fz6a5dz44f9z8cc4za80841a98598
Vandenberghe, M. E. (2015) · theses.fr (ABES) · doi:10.70675/c7b69fb2z393bz46fcz9000z5a9c52ba79c4 · Cited by 1
Souchet, B. (2018) · theses.fr (ABES) · doi:10.70675/5510ef76zecf1z41f2z9496z015aa6a093be
Malézieux, M. (2018) · theses.fr (ABES) · doi:10.70675/a57fb9f7z01b7z450bza4ccz168a5b84253c
Freyssin, A. (2020) · theses.fr (ABES) · doi:10.70675/0db2e37dz547bz4731z852dz9b843c062cba
Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Lam, S. (2021) · theses.fr (ABES) · doi:10.70675/60b353ffz56fcz41a2z9e53zf0d9ac078167 · Cited by 1
Moreira-de-Sá, A. (2024) · theses.fr (ABES) · doi:10.70675/3e418ab2ze9a3z43e4z9d87ze5870aefddac
Ngan, E., Bhandari, P., Parekh, P. A., Badachhape, A., Annapragada, A., Ghaghada, K. B., & Starosolski, Z. A. (2026) · BMC Medical Imaging · doi:10.1186/s12880-026-02337-9
Kushwaha, S., & Karunakaran, S. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116208
In vitro and in vivo inhibition of amyloid β aggregation by a Ru( ii )–naphthalene diimide complex
Tiburcio, M. A., Cali, M. P., Pereira, L. M. B., Graminha, A. E., Atienza‐Navarro, I., Vendruscolo, M., Garcı́a-Alloza, M., & Carlos, R. M. (2026) · Dalton Transactions · doi:10.1039/d5dt02853a
Circadian disruption induces sex-specific Alzheimer’s pathophysiology and immune cell reprogrammingPreprint
Cordi, C. V., Falkenberg, N. G., Clark, G. T., Allen, N. G., Chuah, J., Ulbrich, R., Herzog, A. A., Lanka, M., Collins, E. J., Bentley, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.30.721994
Choudhury, R. R., Kushwaha, S., & Karunakaran, S. (2026) · Neuroscience Letters · doi:10.1016/j.neulet.2026.138618
Katsuki, F., McNally, J. M., Gerashchenko, D., Uygun, D. S., Tyler, A., McCoy, J. G., McKenna, J. T., & Brown, R. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.26.725476
Pan, W., Yang, L., Zhang, Y., Chen, Y., Xu, Y., Li, Y., Fu, Y., Ma, C., Liu, C., Li, Q., et al. (2026) · Science Advances · doi:10.1126/sciadv.adz0887
Zhang, Y., Qiao, H., Lv, Z., Guo, R., Li, D., Song, W., & Wang, D. (2026) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1177/25785478261465371
Kasongo, A. A., Bhunu, B., Boucher, D. M., Vijithakumar, V., Aly, S. H., Emerton, C., Rousseaux, M. W. C., Lagace, D. C., & Ouimet, M. (2026) · Neuroscience Letters · doi:10.1016/j.neulet.2026.138682
Yarmush, M. L. (2026) · Innovation and Emerging Technologies · doi:10.1142/s273759942620001x
Zhang, X., Yang, X., Zhuang, D., Mu, Z., & Ju, C. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116391
Zhang, X., Zhuang, D., Lai, C., Zheng, C., Soh, Z. D., Wagner, S. K., Cai, V. Y., Yang, Z., Wang, S., Geng, X., et al. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101504
KHAN, F. B., Mandloi, A. S., Shahadat, M., Mohan, A. J., Kilor, V. A., Sapkal, N. P., & Dhote, V. V. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108825
Müller, L., Köhler, C., Lindner, T., Polei, S., Vollmar, B., Weber, M. D., Krause, B. J., Kirschstein, T., Porath, K., Engel, N., et al. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00872-9
Peck, B. D., O’Hare, N. R., Ferris, C. F., Pinals, R. L., & Ebong, E. E. (2026) · Methods · doi:10.1016/j.ymeth.2026.09.003
A validated deep learning workflow for 3D quantification of amyloid plaques in cleared mouse brain
Valova, V., Cole, L., Rodriguez, N. F., Braet, F., Johnstone, D. M., & Harwood, R. (2026) · Journal of Microscopy · doi:10.1111/jmi.70179
Toll-Like Receptor 2 and Partner Receptors in Alzheimers Disease
Shirong, L. (2011) · Publications of the UdS (Saarland University) · doi:10.22028/d291-21508
Untersuchungen zur Rekrutierung myeloischer Zellen in einem Tiermodell der Alzheimerschen Erkrankung
Schlevogt, B. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1158
Metadata
- Authors
- Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P.
- Affiliations
- Harvard University (US)
- Corresponding author
- Frosch, Matthew P.
- ORCID
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 24
- Issue
- 3
- Pages
- 516-524
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2005719973
- Cited by
- 744
- References
- 46
- Citations by year
- 2026: 36 · 2025: 28 · 2024: 39 · 2023: 28 · 2022: 41 · 2021: 46 · 2020: 53 · 2019: 43 · 2018: 57 · 2017: 44 · 2016: 45 · 2015: 49 · 2014: 47 · 2013: 51 · 2012: 42
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- green
- doaj.org
- Licence
- Locations
- Neurobiology of Disease (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Chinese Academy of Agricultural Sciences
- National Institutes of Health
- National Institute on Aging (R01AG021084, AG021084, R01AG020570, AG 020570)
- National Institute of Biomedical Imaging and Bioengineering (EB 000768, R01EB000768)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- amyloid-beta deposition, APP/PS1 mice, Alzheimer's disease, transgenic mouse model, amyloid plaques, cerebral amyloid angiopathy, multiphoton microscopy, Tg2576 mice
- MeSH terms
- Age Factors, Alzheimer Disease, Animals, Brain, Disease Models, Animal, Mice, Neurologic Mutants, Mice, Transgenic, Tissue Distribution, Amyloid beta-Protein Precursor, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
